Brind.

Biotech Leader Wins Award for Dual-Payload ADC Development

1 report, 1 independent Updated Oct 15
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Leaders from Callio Therapeutics presented at World ADC San Diego 2026 in Singapore, delivering three presentations and two panel discussions on dual-payload ADC resistance and linker design. The company also won Best New ADC Drug Developer at the 13th World ADC Awards, which were held on October 14.

From manilatimes.net

Why it matters

Some supportBrind's analysis of the reports

The recognition highlights progress in advancing dual-payload antibody-drug conjugates (ADCs) designed to overcome treatment resistance in tumors. Callio Therapeutics is developing a pipeline of these ADCs, with CLIO-8221 being the first program to enter the clinic.

From manilatimes.net

Who's involved

  • Zachary HornbyChief Executive Officer of Callio Therapeutics, who accepted the award

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped